Universitätsklinikum Frankfurt am Main R. Knecht Universitätsklinikum Frankfurt am Main R. Knecht Induction chemotherapy TPF 3 Cycles Docetaxel 75mg/m.
Squamous Cell H&N Cancer Hypopharynx Therapeutic Approach Ricardo Hitt MD, PhD Hospital Universitario 12 Octubre MADRID STATEMENTS 2008.
p53 adapted neoadjuvant therapy for esophageal cancer: Pilot study